US Patent No. 8,996,318

Using oligonucleotide microarrays to analyze genomic differences for the prediction of heterosis
Apr 27, 2015

Pioneer Hi-Bred and DuPont have been awarded US Patent No. 8,996,318, "Using oligonucleotide microarrays to analyze genomic differences for the prediction of heterosis."

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.